Evolving racial/ethnic disparities in AML survival in the novel therapy era.
Wang X, Gimotty PA, Matthews AH, Mamtani R, Luger SM, Hexner EO, Babushok DV, McCurdy SR, Frey NV, Bruno XJ, Gill S, Martin ME, Paralkar VR, Maillard I, Porter DL, Loren AW, Perl AE, Pratz KW, Getz KD, Lai C.
Wang X, et al. Among authors: lai c.
Blood Adv. 2025 Feb 11;9(3):533-544. doi: 10.1182/bloodadvances.2024014127.
Blood Adv. 2025.
PMID: 39888631